Xiao Zhao

机构：Sun Yat-sen University, Chinese PLA General Hospital, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Third Affiliated Hospital of Sun Yat-sen University

发表论文 44 篇 · 总被引 513 次 · h-index 13

代表论文

• Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase (2020 · Cancer Immunology Immunotherapy · 被引 75)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer (2025 · npj Precision Oncology · 被引 19)
• Genomic profiling of Chinese patients with urothelial carcinoma (2021 · BMC Cancer · 被引 14)
• Harnessing machine learning and multi-omics to explore tumor evolutionary characteristics and the role of AMOTL1 in prostate cancer (2024 · International Journal of Biological Macromolecules · 被引 13)
• Driver gene alterations profiling of Chinese non‐small cell lung cancer and the effects of co‐occurring alterations on immunotherapy (2021 · Cancer Medicine · 被引 13)